148 related articles for article (PubMed ID: 11380215)
1. Clinical significance of serum pulmonary surfactant proteins a and d for the early detection of radiation pneumonitis.
Sasaki R; Soejima T; Matsumoto A; Maruta T; Yamada K; Ota Y; Kawabe T; Nishimura H; Sakai E; Ejima Y; Sugimura K
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):301-7. PubMed ID: 11380215
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis.
Takahashi H; Imai Y; Fujishima T; Shiratori M; Murakami S; Chiba H; Kon H; Kuroki Y; Abe S
Eur Respir J; 2001 Mar; 17(3):481-7. PubMed ID: 11405529
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis.
Takahashi H; Kuroki Y; Tanaka H; Saito T; Kurokawa K; Chiba H; Sagawa A; Nagae H; Abe S
Am J Respir Crit Care Med; 2000 Jul; 162(1):258-63. PubMed ID: 10903251
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous measurements of KL-6 and SP-D in patients undergoing thoracic radiotherapy.
Matsuno Y; Satoh H; Ishikawa H; Kodama T; Ohtsuka M; Sekizawa K
Med Oncol; 2006; 23(1):75-82. PubMed ID: 16645232
[TBL] [Abstract][Full Text] [Related]
5. [Surfactant proteins A and D as biomarkers of disease activity in diffuse interstitial pneumonia].
Abe S; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2000 Mar; 38(3):157-65. PubMed ID: 10846395
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia].
Honda Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():181-5. PubMed ID: 9216212
[TBL] [Abstract][Full Text] [Related]
7. Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 1. Diffuse infiltrative lung disease--new clinical biomarker in diffuse interstitial pneumonia.
Abe S; Takahashi H
Intern Med; 2001 Feb; 40(2):159-62. PubMed ID: 11300154
[No Abstract] [Full Text] [Related]
8. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary surfactant proteins SP-A and SP-D].
Kuroki Y; Takahashi H
Nihon Rinsho; 1999 Aug; 57 Suppl():309-12. PubMed ID: 10503429
[No Abstract] [Full Text] [Related]
10. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
Greene KE; King TE; Kuroki Y; Bucher-Bartelson B; Hunninghake GW; Newman LS; Nagae H; Mason RJ
Eur Respir J; 2002 Mar; 19(3):439-46. PubMed ID: 11936520
[TBL] [Abstract][Full Text] [Related]
11. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance.
Honda Y; Kuroki Y; Shijubo N; Fujishima T; Takahashi H; Hosoda K; Akino T; Abe S
Respiration; 1995; 62(2):64-9. PubMed ID: 7784711
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of SP-D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy.
Xu L; Jiang J; Li Y; Zhang L; Li Z; Xian J; Jiang C; Diao Y; Su X; Xu H; Zhang Y; Zhang T; Yang Z; Tan B; Li H
Cancer Med; 2019 May; 8(5):2599-2611. PubMed ID: 30897289
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases.
Kuwano K; Maeyama T; Inoshima I; Ninomiya K; Hagimoto N; Yoshimi M; Fujita M; Nakamura N; Shirakawa K; Hara N
Respirology; 2002 Mar; 7(1):15-21. PubMed ID: 11896896
[TBL] [Abstract][Full Text] [Related]
14. [A case of severe Legionella pneumonia monitored with serum SP-A, SP-D, and KL-6].
Sukoh N; Yamamoto H; Kikuchi E; Suzuki T; Kamimura A; Watanabe N; Takahashi H; Abe S; Tateda K
Nihon Kokyuki Gakkai Zasshi; 2001 Feb; 39(2):126-30. PubMed ID: 11321824
[TBL] [Abstract][Full Text] [Related]
15. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent.
Takahashi H; Fujishima T; Koba H; Murakami S; Kurokawa K; Shibuya Y; Shiratori M; Kuroki Y; Abe S
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1109-14. PubMed ID: 10988138
[TBL] [Abstract][Full Text] [Related]
16. An in-house ELISA method for measuring surfactant protein A.
Cheong KB; Cheong SK; Boo NY; Jemilah M; Ton SH
Malays J Pathol; 1995 Dec; 17(2):91-6. PubMed ID: 8935133
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of levels of lung surfactant protein A in serum, in various lung diseases].
Abe S; Honda Y; Ando M; Saita N; Kida K; Jinno S; Kondo A; Kuroki Y; Akino T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1219-25. PubMed ID: 8583713
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors.
Hara R; Itami J; Komiyama T; Katoh D; Kondo T
Chest; 2004 Jan; 125(1):340-4. PubMed ID: 14718465
[TBL] [Abstract][Full Text] [Related]
19. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy.
Yamashita H; Kobayashi-Shibata S; Terahara A; Okuma K; Haga A; Wakui R; Ohtomo K; Nakagawa K
Radiat Oncol; 2010 May; 5():32. PubMed ID: 20459699
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary surfactant protein A in sera for assessing neonatal lung maturation.
Kaneko K; Shimizu H; Arakawa H; Ogawa Y
Early Hum Dev; 2001 Apr; 62(1):11-21. PubMed ID: 11245991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
